Title: Subramaniam Prem S, et al. Targeting nonclassical oncogenes for therapy in T-ALL. Cancer cell (2012), 21(4), 459-72.
1431697-74-3
870281-34-8
1146702-54-6
870281-17-7
474012-90-3
1365267-35-1 | Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | AA009CCM | MFCD28358884
1246814-53-8 | Nepafenac-D5 | AA009CGK | MFCD08067732
1429624-84-9 | PI4KIIIbeta-IN-9 | AA009CKQ | MFCD30187516
134099-20-0 | 2,3-Difluoro-4-(trifluoromethyl)benzaldehyde | AA009D2O | MFCD00236254
1286686-22-3 | Potassium (phenylsulfonamido)methyltrifluoroborate | AA009DCG | MFCD19288892
1256643-45-4 | 3-Methyl-3,9-diazaspiro[5.6]dodecane | AA009DP8 | MFCD18381891
134541-04-1 | 5-Propylisoxazole-4-carboxylic acid | AA009DUA | MFCD09756503
1346598-67-1 | 2-BroMo-1,3-propanediol-d4 | AA009DZZ
1312905-33-1 | 8-Bromo-1-methylisoquinoline | AA009E6B | MFCD22689698
1227606-17-8 | 5-Chloro-3-(chloromethyl)-2-fluoropyridine | AA009EFJ | MFCD16608118